Amend CSHB 800 (house committee report) on page 11, between lines 10 and 11, by inserting the following:
Sec. 171.664. ELIGIBILITY OF ENTITY TO RECEIVE GRANTS; DRUG SCREENING AND TESTING. (a) Each owner, partner, board member, chief executive officer, and chief financial officer of an entity receiving an exemption under this subchapter shall submit to a drug use screening assessment to establish the entity's eligibility to receive the exemption.
(b) An individual whose drug use screening assessment conducted under this section indicates good cause to suspect the individual is using a substance that is subject to regulation under Chapter 481, Health and Safety Code, shall submit to a drug test to establish the eligibility of an entity to receive the exemption under this subchapter.
(c) An entity is ineligible to receive an exemption under this subchapter if the drug test of the entity's owner, partner, board member, chief executive officer, or chief financial officer conducted under this section indicates the presence in the individual's body of a substance that is subject to regulation under Chapter 481, Health and Safety Code, not prescribed for the individual by a health care practitioner. The entity's ineligibility remains in effect until the last day of the sixth month after the date the drug test was administered.
(d) The comptroller shall use the most efficient and cost-effective drug use screening assessment tool that can be validated for purposes of this section.
(e) The comptroller shall adopt rules to implement this section.